Related references
Note: Only part of the references are listed.SUMOylation regulates the number and size of promyelocytic leukemia-nuclear bodies (PML-NBs) and arsenic perturbs SUMO dynamics on PML by insolubilizing PML in THP-1 cells
Seishiro Hirano et al.
ARCHIVES OF TOXICOLOGY (2022)
A Tale of Usurpation and Subversion: SUMO-Dependent Integrity of Promyelocytic Leukemia Nuclear Bodies at the Crossroad of Infection and Immunity
Upayan Patra et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies
Zhe Sha et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
TGF-β induces PML SUMOylation, degradation and PML nuclear body disruption
Faten El-Asmi et al.
CYTOKINE (2019)
Interplay between ubiquitylation and SUMOylation: Empowered by phase separation
Jianping Jin
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Irreversibility of arsenic trioxide induced PML/RARα fusion protein solubility changes
Yasen Maimaitiyiming et al.
METALLOMICS (2019)
RING tetramerization is required for nuclear body biogenesis and PML sumoylation
Pengran Wang et al.
NATURE COMMUNICATIONS (2018)
Coordinated collective migration and asymmetric cell division in confluent human keratinocytes without wounding
Emma Lang et al.
NATURE COMMUNICATIONS (2018)
A Systems-Level Study Reveals Regulators of Membrane-less Organelles in Human Cells
Doris Berchtold et al.
MOLECULAR CELL (2018)
Solubility changes of promyelocytic leukemia (PML) and SUMO monomers and dynamics of PML nuclear body proteins in arsenite-treated cells
Seishiro Hirano et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2018)
Human Regulatory Protein Ki-1/57 Is a Target of SUMOylation and Affects PML Nuclear Body Formation
Angela Saito et al.
JOURNAL OF PROTEOME RESEARCH (2017)
MG132-induced progerin clearance is mediated by autophagy activation and splicing regulation
Karim Harhouri et al.
EMBO MOLECULAR MEDICINE (2017)
Compositional Control of Phase-Separated Cellular Bodies
Salman F. Banani et al.
CELL (2016)
SUMO deconjugation is required for arsenic-triggered ubiquitylation of PML
Domenico Fasci et al.
SCIENCE SIGNALING (2015)
Solubility shift and SUMOylaltion of promyelocytic leukemia (PML) protein in response to arsenic(III) and fate of the SUMOylated PML
Seishiro Hirano et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2015)
SUMO deconjugation is required for arsenic-triggered ubiquitylation of PML
Domenico Fasci et al.
SCIENCE SIGNALING (2015)
SUMOylation Blocks the Ubiquitin-Mediated Degradation of the Nephronophthisis Gene Product Glis2/NPHP7
Haribaskar Ramachandran et al.
PLOS ONE (2015)
Nuclear bodies: new insights into assembly/dynamics and disease relevance
Judith E. Sleeman et al.
CURRENT OPINION IN CELL BIOLOGY (2014)
Oxidative stress-induced assembly of PML nuclear bodies controls sumoylation of partner proteins
Umut Sahin et al.
JOURNAL OF CELL BIOLOGY (2014)
Cytoplasmic localization of PML particles in laminopathies
F. Houben et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2013)
Effects of arsenic on modification of promyelocytic leukemia (PML): PML responds to low levels of arsenite
Seishiro Hirano et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Differential roles of PML isoforms
Sebastien Nisole et al.
FRONTIERS IN ONCOLOGY (2013)
Trajectories and nuclear arrangement of PML bodies are influenced by A-type lamin deficiency
Lenka Stixova et al.
BIOLOGY OF THE CELL (2012)
The arsenic-based cure of acute promyelocytic leukemia promotes cytoplasmic sequestration of PML and PML/RARA through inhibition of PML body recycling
Emma Lang et al.
BLOOD (2012)
Requirement of PML SUMO Interacting Motif for RNF4-or Arsenic Trioxide-Induced Degradation of Nuclear PML Isoforms
Mohamed Ali Maroui et al.
PLOS ONE (2012)
Curing APL through PML/RARA degradation by As2O3
Valerie Lallemand-Breitenbach et al.
TRENDS IN MOLECULAR MEDICINE (2012)
Missense mutations in PML-RARA are critical for the lack of responsiveness to arsenic trioxide treatment
Emi Goto et al.
BLOOD (2011)
The SUMO protease SENP6 is a direct regulator of PML nuclear bodies
Neil Hattersley et al.
MOLECULAR BIOLOGY OF THE CELL (2011)
PML/RARA Oxidation and Arsenic Binding Initiate the Antileukemia Response of As2O3
Marion Jeanne et al.
CANCER CELL (2010)
Arsenic Trioxide Controls the Fate of the PML-RARα Oncoprotein by Directly Binding PML
Xiao-Wei Zhang et al.
SCIENCE (2010)
PML Nuclear Bodies
Valerie Lallemand-Breitenbach et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Cell-cycle regulation and dynamics of cytoplasmic compartments containing the promyelocytic leukemia protein and nucleoporins
Asne Jul-Larsen et al.
JOURNAL OF CELL SCIENCE (2009)
Changing Nuclear Landscape and Unique PML Structures During Early Epigenetic Transitions of Human Embryonic Stem Cells
John T. Butler et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation
Michael H. Tatham et al.
NATURE CELL BIOLOGY (2008)
Arsenic degrades PML or PML - RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway
Valerie Lallemand-Breitenbach et al.
NATURE CELL BIOLOGY (2008)
SUSP1 antagonizes formation of highly SUMO2/3-conjugated species
Debaditya Mukhopadhyay et al.
JOURNAL OF CELL BIOLOGY (2006)
The number of PML nuclear bodies increases in early S phase by a fission mechanism
G Dellaire et al.
JOURNAL OF CELL SCIENCE (2006)
Mitotic accumulations of PML protein contribute to the re-establishment of PML nuclear bodies in G1
G Dellaire et al.
JOURNAL OF CELL SCIENCE (2006)
Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3
CH Fu et al.
ONCOGENE (2005)
All-trans retinoic acid/AS2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia
ZX Shen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The role of PML in tumor suppression
P Salomoni et al.
CELL (2002)
PML protein isoforms and the RBCC/TRIM motif
K Jensen et al.
ONCOGENE (2001)
Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot
D Negorev et al.
ONCOGENE (2001)
Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor α degradation
V Lallemand-Breitenbach et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Share Paper
